Year archive

Simcere Pharmaceutical Group Limited — 2023 filings

All 103 regulatory filings released by Simcere Pharmaceutical Group Limited (S2P) in 2023, sourced directly from the official regulator.

103 Filings

2023 Period

2023 filings (103)

Filing	Released	Lang
CONTINUING CONNECTED TRANSACTIONS - (1) ORDER COLLECTION COMPREHENSIVE SERVICES AGREEMENT; AND (2) EXCLUSIVE PROMOTION SERVICES COOPERATION AGREEMENT Regulatory Filings	2023-12-29	English
VOLUNTARY ANNOUNCEMENT - LOCALIZATION APPLICATION OF COSELA (TRILACICLIB HYDROCHLORIDE FOR INJECTION) APPROVED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA Regulatory Filings	2023-12-27	English
Next Day Disclosure Return Regulatory Filings	2023-12-22	English
Next Day Disclosure Return Regulatory Filings	2023-12-21	English
Next Day Disclosure Return Regulatory Filings	2023-12-18	English
VOLUNTARY ANNOUNCEMENT - THE INCLUSION OF XIANNUOXIN, AN ANTI-SARS-COV-2 INNOVATIVE DRUG, IN THE NEW NATIONAL REIMBURSEMENT DRUG LIST Regulatory Filings	2023-12-13	English
Next Day Disclosure Return Regulatory Filings	2023-12-07	English
VOLUNTARY ANNOUNCEMENT - APPROVAL OF INVESTIGATIONAL NEW DRUG FOR SIM0501 (AN USP1 SMALL-MOLECULE INHIBITOR) ISSUED BY U.S. FOOD AND DRUG ADMINISTRATION Regulatory Filings	2023-12-04	English
Next Day Disclosure Return Regulatory Filings	2023-12-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023 Regulatory Filings	2023-12-04	English
VOLUNTARY ANNOUNCEMENT - THE CLINICAL TRIAL APPROVAL FOR NEW INDICATION OF SANBEXIN SUBLINGUAL TABLETS ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2023-11-30	English
VOLUNTARY ANNOUNCEMENT - ENTERING INTO AN EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT WITH CONNECT BIOPHARMA IN RELATION TO IL-4Ra MONOCLONAL ANTIBODY RADEMIKIBART Regulatory Filings	2023-11-21	English
CHANGE OF REGISTERED OFFICE ADDRESS Regulatory Filings	2023-11-17	English
Next Day Disclosure Return Regulatory Filings	2023-11-16	English
Next Day Disclosure Return Regulatory Filings	2023-11-10	English
Next Day Disclosure Return Regulatory Filings	2023-11-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023 Regulatory Filings	2023-11-03	English
Next Day Disclosure Return Regulatory Filings	2023-11-02	English
Next Day Disclosure Return Regulatory Filings	2023-10-31	English
VOLUNTARY ANNOUNCEMENT - REGULAR APPROVAL OF COSELA (TRILACICLIB HYDROCHLORIDE FOR INJECTION) APPROVED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA Regulatory Filings	2023-10-30	English
Next Day Disclosure Return Regulatory Filings	2023-10-27	English
Next Day Disclosure Return Regulatory Filings	2023-10-26	English
Next Day Disclosure Return Regulatory Filings	2023-10-25	English
Next Day Disclosure Return Regulatory Filings	2023-10-24	English
(Revised) Next Day Disclosure Return Regulatory Filings	2023-10-20	English
Next Day Disclosure Return Regulatory Filings	2023-10-20	English
Next Day Disclosure Return Regulatory Filings	2023-10-19	English
Next Day Disclosure Return Regulatory Filings	2023-10-18	English
Next Day Disclosure Return Regulatory Filings	2023-10-17	English
VOLUNTARY ANNOUNCEMENT - THE CLINICAL TRIAL APPROVAL FOR NEW INDICATION OF SIM0237 FOR INJECTION (ANTI-PD-L1/IL-15 BISPECIFIC ANTIBODY) ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2023-10-16	English
Next Day Disclosure Return Regulatory Filings	2023-10-16	English
Next Day Disclosure Return Regulatory Filings	2023-10-13	English
Next Day Disclosure Return Regulatory Filings	2023-10-12	English
Next Day Disclosure Return Regulatory Filings	2023-10-10	English
VOLUNTARY ANNOUNCEMENT - ENTERING INTO COOPERATION AGREEMENT WITH ANDICON IN RELATION TO ANTI-INFLUENZA DRUG ADC189 Regulatory Filings	2023-10-10	English
Next Day Disclosure Return Regulatory Filings	2023-10-06	English
Next Day Disclosure Return Regulatory Filings	2023-10-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023 Regulatory Filings	2023-10-05	English
Next Day Disclosure Return Regulatory Filings	2023-10-04	English
Next Day Disclosure Return Regulatory Filings	2023-09-29	English
Next Day Disclosure Return Regulatory Filings	2023-09-28	English
Next Day Disclosure Return Regulatory Filings	2023-09-26	English
Next Day Disclosure Return Regulatory Filings	2023-09-25	English
2023 INTERIM REPORT Regulatory Filings	2023-09-22	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS: NOTICE OF PUBLICATION OF INTERIM REPORT 2023 Regulatory Filings	2023-09-22	English
Next Day Disclosure Return Regulatory Filings	2023-09-21	English
Next Day Disclosure Return Regulatory Filings	2023-09-20	English
Next Day Disclosure Return Regulatory Filings	2023-09-19	English
Next Day Disclosure Return Regulatory Filings	2023-09-18	English
Next Day Disclosure Return Regulatory Filings	2023-09-15	English
Next Day Disclosure Return Regulatory Filings	2023-09-14	English
Next Day Disclosure Return Regulatory Filings	2023-09-13	English
Next Day Disclosure Return Regulatory Filings	2023-09-12	English
Next Day Disclosure Return Regulatory Filings	2023-09-11	English
Next Day Disclosure Return Regulatory Filings	2023-09-07	English
Next Day Disclosure Return Regulatory Filings	2023-09-06	English
Next Day Disclosure Return Regulatory Filings	2023-09-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023 Regulatory Filings	2023-09-05	English
Next Day Disclosure Return Regulatory Filings	2023-09-04	English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2023 Regulatory Filings	2023-08-21	English
VOLUNTARY ANNOUNCEMENT - BUSINESS COOPERATION AGREEMENT WITH MABPHARM IN RELATION TO CMAB009 Regulatory Filings	2023-08-20	English
VOLUNTARY ANNOUNCEMENT - MARKETING APPLICATION OF THE NEW INDICATION OF COSELA (TRILACICLIB HYDROCHLORIDE FOR INJECTION) ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2023-08-14	English
DATE OF BOARD MEETING Regulatory Filings	2023-08-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023 Regulatory Filings	2023-08-03	English
PROFIT ALERT Regulatory Filings	2023-07-27	English
VOLUNTARY ANNOUNCEMENT - SIM0278 INJECTION (IL-2 MUTANT Fc FUSION PROTEIN) OBTAINED THE CLINICAL TRIAL APPROVAL ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2023-07-27	English
VOLUNTARY ANNOUNCEMENT - THE HYPNOTICS DARIDOREXANT HYDROCHLORIDE TABLETS OBTAINED THE CLINICAL TRIAL APPROVAL ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2023-07-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023 Regulatory Filings	2023-07-05	English
Next Day Disclosure Return Regulatory Filings	2023-06-30	English
Next Day Disclosure Return Regulatory Filings	2023-06-29	English
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION (NDA) OF SANBEXIN SUBLINGUAL TABLETS ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2023-06-28	English
GRANT OF AWARDS UNDER THE 2021 RSU SCHEME Regulatory Filings	2023-06-28	English
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE Regulatory Filings	2023-06-26	English
(UPDATED) FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2022 Regulatory Filings	2023-06-15	English
(I) POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 15, 2023 AND (II) PAYMENT OF FINAL DIVIDEND Regulatory Filings	2023-06-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023 Regulatory Filings	2023-06-05	English
RULES OF RESTRICTED SHARE UNIT SCHEME Regulatory Filings	2023-05-24	English
PROXY FORM FOR ANNUAL GENERAL MEETING Regulatory Filings	2023-05-24	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS: NOTICE OF PUBLICATION OF CIRCULAR AND NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2023-05-24	English
NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2023-05-24	English
(I) PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE AND TO REPURCHASE SHARES; (II) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (III) PROPOSED DECLARATION AND PAYMENT OF FINAL DIVIDEND; ( Regulatory Filings	2023-05-24	English
Next Day Disclosure Return Regulatory Filings	2023-05-10	English
COMPLETION OF ISSUE OF NEW SHARES UNDER THE 2021 RSU SCHEME Regulatory Filings	2023-05-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023 Regulatory Filings	2023-05-04	English
VOLUNTARY ANNOUNCEMENT - THE NEW INDICATION OF SANBEXIN (EDARAVONE AND DEXBORNEOL CONCENTRATED SOLUTION FOR INJECTION) OBTAINED THE CLINICAL TRIAL APPROVAL ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMI Regulatory Filings	2023-05-02	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS: NOTICE OF PUBLICATION OF 2022 ANNUAL REPORT AND ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT Regulatory Filings	2023-04-17	English
2022 ANNUAL REPORT Regulatory Filings	2023-04-17	English
2022 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT Regulatory Filings	2023-04-17	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023 Regulatory Filings	2023-04-06	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Regulatory Filings	2023-03-31	English
APPOINTMENT OF MEMBERS OF REMUNERATION AND APPRAISAL COMMITTEE AND NOMINATION COMMITTEE Regulatory Filings	2023-03-31	English
PROPOSED AMENDMENTS TO THE 2021 RSU SCHEME Regulatory Filings	2023-03-31	English
FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2022 Regulatory Filings	2023-03-31	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2022 Regulatory Filings	2023-03-31	English
DATE OF BOARD MEETING Regulatory Filings	2023-03-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023 Regulatory Filings	2023-03-03	English
PROFIT ALERT Regulatory Filings	2023-02-24	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023 Regulatory Filings	2023-02-02	English
VOLUNTARY ANNOUNCEMENT - CONDITIONAL APPROVAL FOR MARKETING IN CHINA OF ANTI-SARS-COV-2 INNOVATIVE DRUG XIANNUOXIN (SIMNOTRELVIR TABLETS/RITONAVIR TABLETS (CO-PACKAGED)) GRANTED BY THE NATIONAL M Regulatory Filings	2023-01-29	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Regulatory Filings	2023-01-18	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON JANUARY 18, 2023 Regulatory Filings	2023-01-18	English
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION OF ANTI-SARS-COV-2 INNOVATIVE DRUG XIANNUOXIN (SIMNOTRELVIR TABLETS/RITONAVIR TABLETS (CO-PACKAGED)) ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINI Regulatory Filings	2023-01-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022 Regulatory Filings	2023-01-05	English